These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38543312)
1. The Physicochemical Compatibility of Sildenafil Injection with Parenteral Medications Used in Neonatal Intensive Care Settings. De Silva DTN; Strunk T; Petrovski M; Page-Sharp M; Moore BR; Batty KT Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543312 [TBL] [Abstract][Full Text] [Related]
2. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. De Silva DTN; Petrovski M; Strunk T; Mukadam N; Page-Sharp M; Moore BR; Batty KT Eur J Clin Pharmacol; 2024 Jul; 80(7):1079-1087. PubMed ID: 38546840 [TBL] [Abstract][Full Text] [Related]
3. Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - A compatibility study. AlSalman F; Howlett M; Breatnach C; Kelly H; O'Brien F Eur J Pharm Biopharm; 2020 Jun; 151():153-161. PubMed ID: 32289494 [TBL] [Abstract][Full Text] [Related]
4. Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection. Holt RJ; Siegert SW; Krishna A J Pediatr Pharmacol Ther; 2008 Jul; 13(3):156-61. PubMed ID: 23055876 [TBL] [Abstract][Full Text] [Related]
5. Physical Compatibility of Alprostadil with Commonly Used IV Solutions and Medications in the Neonatal Intensive Care Unit. Dice JE J Pediatr Pharmacol Ther; 2006 Oct; 11(4):233-6. PubMed ID: 23115539 [TBL] [Abstract][Full Text] [Related]
6. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. De Basagoiti A; Katsumiti A; Abascal S; Bustinza A; López-Giménez LR; Pascual P; De Miguel M; Campino A Eur J Pediatr; 2021 Apr; 180(4):1169-1176. PubMed ID: 33128625 [TBL] [Abstract][Full Text] [Related]
7. Physical compatibility of medications with concentrated neonatal and pediatric parenteral nutrition: A simulated Y-site drug compatibility study. Ross EL; Petty K; Salinas A; Her C; Carpenter JF JPEN J Parenter Enteral Nutr; 2023 Mar; 47(3):372-381. PubMed ID: 36582024 [TBL] [Abstract][Full Text] [Related]
8. Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications. Salamat-Miller N; Turner MA; Bandekar A; Dixit N; Jochim E; Mangum B; McPherson C; Tenjarla S; Singh S; Hwang YS; Barton N World J Pediatr; 2023 Jan; 19(1):58-67. PubMed ID: 36344872 [TBL] [Abstract][Full Text] [Related]
10. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Greenhill K; Hornsby E; Gorman G Pharmaceuticals (Basel); 2019 May; 12(2):. PubMed ID: 31060247 [TBL] [Abstract][Full Text] [Related]
11. Compatibility of medications with 3-in-1 parenteral nutrition admixtures. Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995 [TBL] [Abstract][Full Text] [Related]
12. Medication Safety in Intravenous Therapy: A Compatibility Study of Clonidine with Drugs Frequently Used in Intensive Care. Koller AK; Krebs S; Dörje F Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374362 [TBL] [Abstract][Full Text] [Related]
13. Physical and chemical compatibility of intravenous ciprofloxacin with other drugs. Jim LK Ann Pharmacother; 1993 Jun; 27(6):704-7. PubMed ID: 8329786 [TBL] [Abstract][Full Text] [Related]
14. Compatibility of Omadacycline With Select Parenteral Products in Simulated Y-site Administration. Butler DA; Moolick K; McCray D; Gifford M Clin Ther; 2023 Nov; 45(11):1137-1141. PubMed ID: 37777376 [TBL] [Abstract][Full Text] [Related]
15. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients. Foushee JA; Meredith P; Fox LM; Wilder AG Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625 [TBL] [Abstract][Full Text] [Related]
16. Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion. Garcia J; Garg A; Song Y; Fotios A; Andersen C; Garg S PLoS One; 2018; 13(1):e0190577. PubMed ID: 29298359 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218 [TBL] [Abstract][Full Text] [Related]
18. [Physical compatibility of furosemide in intravenous mixtures for continuous perfusion]. Pérez Juan E; Maqueda Palau M; Arévalo Rubert M; Ribas Nicolau B; Amorós Cerdá SM Enferm Intensiva; 2010; 21(3):96-103. PubMed ID: 20413337 [TBL] [Abstract][Full Text] [Related]
19. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration. Fox LM; Wilder AG; Foushee JA Am J Health Syst Pharm; 2013 Mar; 70(6):520-4. PubMed ID: 23456406 [TBL] [Abstract][Full Text] [Related]
20. Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions. Wilder AG; Foushee JA; Fox LM; Navalle J; Wright AM; Greer MA Int J Pharm Compd; 2020; 24(3):238-241. PubMed ID: 32401743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]